In September 2026, The Wall Street Journal reported that Vitruvian Partners was leading a 600 million dollar investment in Angle Health at a 2.7 billion dollar valuation. The transaction is expected to include 200 million dollars of new equity and a 400 million dollar secondary component providing liquidity to existing shareholders. Other participants named in the report include Town Hall Ventures, Blumberg Capital, Portage Ventures, PruVen Capital and Y